Aditxt (ADTX) had the lowest return last year by a US stock or US stock in the Biotechnology Industry, returning -99.9%.

ASSET	YEAR	% RETURN
Aditxt (ADTX)	2024	-99.91%
Psyence Biomedical Ltd Common Shares (PBM)	2024	-99.7%
Allarity Therapeutics (ALLR)	2024	-99.65%
Sunshine Biopharma (SBFM)	2024	-99.48%
CERo Therapeutics Holdings, Inc Common Stock (CERO)	2024	-99.45%
Azitra (AZTR)	2024	-98.6%
Aptevo Therapeutics (APVO)	2024	-98.59%
Transcode Therapeutics (RNAZ)	2024	-98.41%
Universe Pharmaceuticals (UPC)	2024	-97.96%
Tonix Pharmaceuticals (TNXP)	2024	-97.51%
Windtree Therapeutics (WINT)	2024	-97.18%
Revelation Biosciences (REVB)	2024	-96.93%
Lyra Therapeutics (LYRA)	2024	-96.01%
Klotho Neurosciences (KLTO)	2024	-95.47%
Matinas BioPharma (MTNB)	2024	-95.38%
Akanda (AKAN)	2024	-95.36%
Painreform (PRFX)	2024	-94.82%
Cingulate (CING)	2024	-94.2%
Quantum BioPharma (QNTM)	2024	-93.88%
Oragenics (OGEN)	2024	-93.85%
Biodexa Pharmaceticals (BDRX)	2024	-93.84%
RAPT Therapeutics (RAPT)	2024	-93.51%
FibroBiologics, Inc Common Stock (FBLG)	2024	-93.33%
AN2 Therapeutics (ANTX)	2024	-93.15%
Carmell Therapeutics (CTCX)	2024	-92.66%